Skip to main content
. Author manuscript; available in PMC: 2016 Apr 18.
Published in final edited form as: Br J Haematol. 2011 Aug 18;155(2):182–189. doi: 10.1111/j.1365-2141.2011.08831.x

Table II.

Response Rates by Cytogenetic Risk Category or Clofarabine Dose

Cytogenetic Risk Complete Remissions
Favourable 2/3
Intermediate 10/25
Unfavourable 9/18
Cytogenetic Risk Clofarabine dose
15 mg/m2 20 mg/m2 25 mg/m2
Favourable -- -- 2/3
Intermediate 2/4 3/4 5+4CRp/17
Unfavourable 2/4 1/2 6+3CRp/12

CRp, complete remission but with a platelet count <100 x 109/l